Defence Therapeutics Announces Grant of Restricted Stock Units
Montreal, Quebec--(Newsfile Corp. - April 24, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, wishes to announce that the board of directors of the Company approved the grant of 200,000 incentive restricted stock units ("RSUs") to Mr. Sebastien Plouffe, CEO and Director of the Company, vesting immediately. Each RSU entitles the
Biotechnologies, Pharmaceutique, Santé
2026-04-24 6:30 PM EDT | Defence Therapeutics Inc.
UberDoc Health Technologies Corp. Announces Board Transition as Jeffrey Hogan Focuses on The Judi Group
Boston, Massachusetts--(Newsfile Corp. - April 24, 2026) - UberDoc Health Technologies Corp. (CSE: APPT) (FSE: 4KL0), the direct-pay healthcare marketplace for specialty care, today announced that Jeffrey Hogan has stepped down from its Board of Directors. Hogan will focus his attention on the Judi Group, the healthcare advisory firm he co-founded in January 2026 to address fiduciary compliance and cost transparency in employer-sponsored health plans. Hogan brought more than four de
2026-04-24 5:00 PM EDT | UberDoc
MyndTec Inc. Makes Voluntary Assignment in Bankruptcy Under the Bankruptcy and Insolvency Act (Canada)
Mississauga, Ontario--(Newsfile Corp. - April 24, 2026) - Further to its press release dated April 8, 2026, MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company") announced today that, having been unable to secure the additional financing required to continue operations, it has made a voluntary assignment in bankruptcy for the general benefit of its creditors pursuant to section 49 of the Bankruptcy and Insolvency Act (Canada) (the "BIA"). After care
Technologies, Soins de santé et hôpitaux, Santé
2026-04-24 4:41 PM EDT | MyndTec Inc.
Vector Science and Therapeutics Announces Listing on the TSX Venture Exchange
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) (formerly OpenSesame Acquisition Corp.) ("Vector" or the "Company") is pleased to announce the completion of its previously announced qualifying transaction (the "Qualifying Transaction") under Policy 2.4 - Capital Pool Companies of the TSX Venture Exchange (the "TSXV"). Trading of the shares of the Company is expected to resume on the TSXV on
2026-04-24 1:02 PM EDT | Vector Science and Therapeutics Corp. (formerly OpenSesame Acquisition Corp.)
Mobile-health Network Solutions Announces Acquisition of Additional 35MW AI Data Centre Capacity, Expanding Total Secured Capacity to 60MW
Singapore, Singapore--(Newsfile Corp. - April 24, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company") today announced that it has secured an additional 35 megawatts (MW) of high-density artificial intelligence (AI) data centre capacity through its subsidiary PP GRID SDN. BHD. (PPG). With this latest acquisition, a total of 60MW of AI data centre capacity is now secured under the PPG platform. This newly secured 35MW
2026-04-24 9:32 AM EDT | Mobile-health Network Solutions
Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments
Toronto, Ontario--(Newsfile Corp. - April 24, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is pleased to highlight continued expansion and execution of clinical supply shipments of PEX010, a botanical psilocybin drug candidate developed by Filament Health Corp., to leading Canadian research institutions. Following its press release dated April 7, 2026, Red Light is highlighting recent accomplishments and ongoing momentum, including
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-24 8:26 AM EDT | Red Light Holland Corp.
Core Progression Elite Personal Training and Vitelize Health Launch Colorado's First Gym-Integrated GLP-1 Weight-Loss Program
Denver, Colorado--(Newsfile Corp. - April 23, 2026) - Core Progression Elite Personal Training ("Core Progression") and Vitelize Health ("Vitelize") have launched a coordinated GLP-1 weight-loss model that places independent, physician-directed clinics inside Core Progression studios. Vitelize operates on-site clinics at two Denver-metro locations, with program access available to members and clients across all Core Progression De
2026-04-23 7:44 PM EDT | Vitelize Health
Restart Life Sciences' Wholly Owned Subsidiary Holy Crap Foods Reports over 500,000 Units Sold, Highlighting Strong Consumer Adoption
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"), has surpassed 500,000 units sold from January 2023 through March 2026. This milestone reflects continued consumer adoption, repeat purchasing behavior, and steady brand development within the "better-for-you" food category. The C
Technologies, Biotechnologies, Santé
2026-04-23 8:00 AM EDT | Restart Life Sciences Corp.
Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector
Toronto, Ontario--(Newsfile Corp. - April 23, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, today highlights recent U.S. federal policy developments supporting psychedelic research and outlines the potential implications for the sector and the Company. Recent announcements by U.S. President Donald Trump include an exec
Cannabis, Santé, Psychédéliques, Producteurs de cannabis
2026-04-23 7:30 AM EDT | Psyched Wellness Ltd.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
King of Prussia, Pennsylvania--(Newsfile Corp. - April 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will provide an overview of the Company's INTASYL siRNA platform and discuss recent clinical progress and priorities,
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-04-23 7:00 AM EDT | Phio Pharmaceuticals Corp.
Optimi Health Files LIFE Offering Document in Connection with NASDAQ Listing
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that further to its press release dated March 16, 2026, it intends to complete a portion of its previously announced offering of common shares (the "Offering") in Canada pursuant to the Listed Issuer Financing Exemption c
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-04-23 7:00 AM EDT | Optimi Health Corp.
Delivra Health Brands Enters into Licence Agreement with Peak Processing to Manufacture and Distribute Its Topical Brand LivRelief Infused(TM)
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Delivra Health Brands Inc. (TSXV: DHB) OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, announced today that its wholly-owned subsidiary, LivCorp Inc., has entered into a licence agreement ("Licence Agreement") with Peak Processing Solutions ("Peak") (ASX: PKP), to manufacture, distribute and sell infu
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-04-22 5:45 PM EDT | Delivra Health Brands Inc.
Promino Provides Update Respecting Private Placement
Burlington, Ontario--(Newsfile Corp. - April 22, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company") announces, further to its news release dated March 13, 2026, that it is progressing towards completion of a non-brokered private placement (the "Offering") for up to $1,200,000 in gross proceeds, through the issuance of up to 40,000,000 units of the Company ("Units") at a price of $0.03 per Unit. Each Unit wil
Aliments / boissons, Sports, Santé
2026-04-22 5:13 PM EDT | Promino Nutritional Sciences, Inc.
Unbuzzd Wellness Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM ("unbuzzd") — the scientifically-proven and game-changing beverage proven to accelerate alcohol metabolism, restore mental clarity and reduce hangover symptoms, is pleased to announce the appointment of Mr. Richard Buzbuzian as Chief Executive Officer. This marks a pivotal milestone in the Company's commer
2026-04-22 9:01 AM EDT | Unbuzzd Wellness Inc.
Adia Nutrition, Inc. Looking to Acquire Larger Property to Expand Flagship Clinic in Winter Park, Reports Strong Operational Momentum in Q1 2026 and Provides Optimistic Outlook for Remainder of the Year
Winter Park, Florida--(Newsfile Corp. - April 22, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and biologic products through its Adia Med clinics and Adia Labs division, today announced that it is actively looking to acquire a larger property to expand its flagship Adia Med clinic in Winter Park, Florida. This strategic initiative aims to significantly increase the clinic's size and capacity, enabling expanded patient access to advanced r
Soins de santé et hôpitaux, Santé
2026-04-22 8:00 AM EDT | Adia Nutrition Inc.
Functional Brands Inc. Enters Strategic Partnership with partnrup.ai to Accelerate Growth of Tru2u.health
Lake Oswego, Oregon--(Newsfile Corp. - April 22, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced a strategic technology partnership with partnrup.ai, a next-generation artificial intelligence platform purpose-built to support and improve partner-driven customer acquisition. The partnership will deploy partnrup.ai's full technology stack on behalf of Tru2u.health, a digital health platform dedicated to helping individuals
Produits ménagers / de consommation / cosmétiques, Santé
2026-04-22 8:00 AM EDT | Functional Brands Inc.
Restart Life Sciences Provides Performance and Revenue Trend Update on Newly Acquired Superseed Cereals and Oatmeal Brand Portfolio
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide an operational update on its wholly owned subsidiary following the successful completion of its acquisition of Holy Crap Foods Inc. Since the closing of the transaction on February 27, 2026, Restart has been transitioning ownership and integrating portfolio operations under its leadership. The Compa
Technologies, Biotechnologies, Santé
2026-04-22 6:00 AM EDT | Restart Life Sciences Corp.
PreveCeutical Announces Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered private placement (the "Offering") of up to 40,000,000 units (each, a "Unit") in the capital of the Company at a price of $0.
Biotechnologies, Pharmaceutique, Santé
2026-04-22 3:00 AM EDT | PreveCeutical Medical Inc.
DiagnosTear Technologies Inc. Announces Adoption of Semi-Annual Reporting
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - DiagnosTear Technologies Inc. ("DiagnosTear" or the "Company") announces that it has adopted a semi-annual financial reporting ("SAR") framework, effective immediately. This change is being made pursuant to British Columbia Securities Commission Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers ("CBO 51-933"). CBO 51-933 allows eligible
2026-04-21 5:00 PM EDT | DiagnosTear Technologies Inc.
TelyRx Announces Year-End 2025 Financial Results
Clearwater, Florida--(Newsfile Corp. - April 21, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today filed audited financial statements for TelyRx, Inc., its wholly-owned subsidiary and reverse takeover acquirer, on SEDAR+ for the year ended December 31, 2025. All dollar amounts are expressed in U.S. dollars. Highlights for the Year and Fourth Quarter of 2025
Soins de santé et hôpitaux, Santé
2026-04-21 4:49 PM EDT | TelyRx